Ahụ ike, Preparations
Drug "Aklasta". ntụziaka
Drug "Aklasta" analogues nke ọgwụ ( "Veroklast", "Blaztera", "Zolendronat-Teva", wdg) na-enwe ike iji nwayọọ na mbibi nke ọkpukpu anụ ahụ. Zelendronovaya acid - n'ọrụ akụrụngwa - a gụnyere ke klas nke bisphosphonates (sịntetik bekee na-egbochi ọkpụkpụ ọnwụ).
Drug "Aklasta". nkọwa
The agwọ ọrịa atara ke ụdị ihe ngwọta maka infusion.
Mgbe igba ogwu n'akwara ochichi, na-arụsi ọrụ ike akụrụngwa a na-ekesa na ọkpụkpụ anụ ahụ ngwa ngwa. Dị ka ndị ọzọ bisphosphonates, zelendronovaya acid a metụtara nanị akụkụ ụfọdụ tumadi na ebe nke ọkpụkpụ resorption (mbibi).
Site na-egbochi mbibi nke, na-arụsi ọrụ ike mgwa adịghị emetụta n'ibu Njirimara, na usoro nke na e guzobere na ọkpụkpụ mineralization.
Drug "Aklasta". Ntuziaka: àmà
The ọgwụ na-kenyere ọkpụkpụ Paget ọrịa (deforming osteitis), postmenopausal osteoporosis (iji belata likelihood nke fractures na spain, femur na ndị ọzọ na ọkpụkpụ na mma ha ịnweta njupụta), maka mgbochi nke fractures nke ọkpụkpụ mgbe unan na hip nkwonkwo.
"Aklasta" n'aka. Ntụziaka: onunu ogwu Usoro
Tupu ochichi nke ọgwụ dị mkpa iji hụ kacha hydration (mmiri saturation) nke organism. Nke a dị mkpa karịsịa na ngwa nke mamịrị ọgwụ.
N'ihi mgbochi nke fractures mgbe a hip mmerụ ahụ na ọgwụgwọ nke osteoporosis postemenopauznogo ọgwụ "Aklasta" nduzi aro ndinọ site igba ogwu n'akwara infusion otu ugboro n'afọ na ego nke ise milligrams (otu ugboro). The ọgwụ ga n'out oge buru calcium Mmeju na vitamin D.
Na ọgwụgwọ nke Paget ọrịa agwọ ọrịa igba ogwu n'akwara "Aklasta"-atụ aro mmega ntụziaka a dose ise milligrams kwa narị milliliters nke otu okenye ihe ngwọta ndinọ ka a otu igba ogwu n'akwara infusion eji usoro. Administration oge - dịghị ihe na-erughị nkeji iri na ise, ọsọ kwesịrị mgbe nile. N'ihi na eziokwu na Paget ọrịa e ji nwayọọ nwayọọ na-mbibi nke ọkpụkpụ, ihe niile ọrịa na a daa ọrịa na-atụ aro oriri nke ọzọ mkpa kwa ụbọchị vitamin D na calcium ke akpa ụbọchị iri mgbe infusion.
The mbụ ochichi ọgwụ 'Aklasta "na-akpata a ruo ogologo oge oge nke kwụsịtụkwara deforming osteitis. Ugbu a, ụfọdụ ozi maka re-ọgwụgwọ nke Paget ọrịa bụ adịghị. Otú ọ dị, ndị dị otú ahụ bụ na o kwere omume, ọ bụrụ na onye ọrịa nwere a nlọghachi azụ. Secondary mmepe nke daa ọrịa e ji na-esonụ atụmatụ: dịghị normalisation nke alkaline phosphatase na ọbara, onye na-abawanye na Ọnọdụ nke ya dị larịị, na ọnụnọ nke na-adakarị mgbaàmà nke Paget ọrịa, kwuru na ọnwa iri na abua mgbe ngwa nke na "Aklasta" dose.
The ọgwụ na-adịghị akwadoro maka ọrịa na oké gbasara akụrụ ọrụ.
Ndị agadi na ndị ọrịa na imeju ọrụ ọrịa onunu ogwu ukpụhọde a chọrọ.
Na enweghị data na mma na irè ojiji "Aklasta" ọgwụ ọjọọ na ọrịa n'okpuru afọ iri na asatọ, ha ọgwụ na-adịghị ndinọ.
Mgbe iwebata nke agwọ ọrịa yiri ka ịzụlite fever, flu-dị ka syndrome ike ọgwụgwụ, omume nke edema (obere), malaise, asthenia, akpata oyi. Ugboro oghom Jeremaya mere ewere dị ka isi ọwụwa, lethargy, dizziness, iku ume ọkụ ọkụ. Mgbe ụfọdụ, ọ ga-akara paresthesia, syncope, tremor, somnolence. Ọrịa nwere ike na-eche ihe mgbu na spain ọkpụkpụ. Ikekwe mmepe nke myalgia, arthralgia, dyspepsia, vomiting, ọgbụgbọ ndị ọzọ mmetụta.
Drug na-contraindicated n'oge lactation, hypocalcemia, afọ ime, hypersensitivity.
Similar articles
Trending Now